ANIMATION

Heart Sciences MyoVista Wavelet ECG Technology

Share this animation:

Coronary heart disease, or CHD, is a leading cause of death in men and women, effecting an estimated 16.5 million adults in the United States. Due to its limitations, current ECG testing leaves many patients undiagnosed.

XVIVO partnered with Heart Sciences to develop an animation describing their MyoVista Wavelet ECG technology that can detect changes in the heart from CHD and other diseases before symptoms appear.

MyoVista Wavelet ECG is revolutionizing conventional electrocardiography, providing significant clinical, technical, and economical advantages for healthcare providers over conventional ECG. This technology now provides physicians more information to enable better risk stratification to identify heart disease earlier.

Share It:
Contact XVIVO

Client


Heart Sciences MyoVista Wavelet ECG Technology

We have received a tremendously enthusiastic response from students, both in freshman biology and sophomore cell biology courses.

Robert Lue, Director of Life Sciences Education, Professor of the Practice of Molecular and Cellular Biology, Harvard University
Share this animation: